Expertise in
6
conditions

Jaroslaw B. Cwikla

30 Warszawska Str, 
Olsztyn, WN, PL 
Expertise in
6
conditions
30 Warszawska Str, 
Olsztyn, WN, PL 

Overview

Jaroslaw Cwikla practices practicing medicine in Olsztyn, Poland.

Mr. Cwikla is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pheochromocytoma, Carcinoid Syndrome, and Appendectomy.

He is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

30 Warszawska Str, Olsztyn, WN 10082, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-label Post Authorization Safety Study to Evaluate the Effect of LysaKare® Infusion on Serum Potassium Levels in GEP-NET Patients Eligible for Lutathera® Treatment
A Multicenter, Open-label Post Authorization Safety Study to Evaluate the Effect of LysaKare® Infusion on Serum Potassium Levels in GEP-NET Patients Eligible for Lutathera® Treatment
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: LysaKare
Study Phase: Phase 4
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
A Phase 3, Prospective, Randomized, Double-blind, Multi-center Study of the Efficacy and Safety of Lanreotide Autogel®/Depot 120 mg Plus BSC vs. Placebo Plus BSC for Tumour Control in Subjects With Well Differentiated, Metastatic and/or Unresectable, Typical or Atypical, Lung Neuroendocrine Tumours
Enrollment Status: Terminated
Publish Date: July 06, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

90 Total Publications

Large-Scale Multi-Cancer Detection by Learning Segmentation from Reports.
Large-Scale Multi-Cancer Detection by Learning Segmentation from Reports.
Journal: Research square
Published: July 29, 2026

Frequently Asked Questions about Jaroslaw B. Cwikla

Is Jaroslaw B. Cwikla a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Jaroslaw B. Cwikla is classified as an Elite expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jaroslaw B. Cwikla participate in research or clinical trials?

Yes. Jaroslaw B. Cwikla has published 90 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Jaroslaw B. Cwikla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cwikla's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile